FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1994501315> ?p ?o ?g. }

• W1994501315 endingPage "678" @default.
• W1994501315 startingPage "670" @default.
• W1994501315 abstract "Colorectal cancer remains one of the most common causes of cancer death in this country. This malignancy is ideally suited for screening because the detection and removal of the precursor adenomatous polyp can prevent most colorectal cancers from ever forming. The choice of a test for screening involves consideration of various individual parameters, including patient age and the presence of risk factors for the development of colorectal cancer. Computed tomographic colonography (CTC) has emerged as the leading imaging technique for colorectal cancer screening in average-risk individuals on the basis of the evidence presented in this paper. The double-contrast barium enema is an alternative imaging test that is appropriate particularly when CTC is not available. In 2008, the American Cancer Society guideline for colorectal cancer screening was revised jointly with the US Multi-Society Task Force on Colorectal Cancer and the ACR to include CTC every 5 years as an option for average-risk individuals. Computed tomographic colonography is also the preferred test for colon evaluation after an incomplete colonoscopy. Imaging tests including CTC and the double-contrast barium enema are usually not indicated for colorectal cancer screening in high-risk patients with polyposis syndromes or inflammatory bowel disease. This paper presents the new colorectal cancer imaging test ratings and is the result of evidence-based consensus by the ACR Appropriateness Criteria® Expert Panel on Gastrointestinal Imaging. Colorectal cancer remains one of the most common causes of cancer death in this country. This malignancy is ideally suited for screening because the detection and removal of the precursor adenomatous polyp can prevent most colorectal cancers from ever forming. The choice of a test for screening involves consideration of various individual parameters, including patient age and the presence of risk factors for the development of colorectal cancer. Computed tomographic colonography (CTC) has emerged as the leading imaging technique for colorectal cancer screening in average-risk individuals on the basis of the evidence presented in this paper. The double-contrast barium enema is an alternative imaging test that is appropriate particularly when CTC is not available. In 2008, the American Cancer Society guideline for colorectal cancer screening was revised jointly with the US Multi-Society Task Force on Colorectal Cancer and the ACR to include CTC every 5 years as an option for average-risk individuals. Computed tomographic colonography is also the preferred test for colon evaluation after an incomplete colonoscopy. Imaging tests including CTC and the double-contrast barium enema are usually not indicated for colorectal cancer screening in high-risk patients with polyposis syndromes or inflammatory bowel disease. This paper presents the new colorectal cancer imaging test ratings and is the result of evidence-based consensus by the ACR Appropriateness Criteria® Expert Panel on Gastrointestinal Imaging." @default.
• W1994501315 created "2016-06-24" @default.
• W1994501315 creator A5008553954 @default.
• W1994501315 creator A5015780422 @default.
• W1994501315 creator A5023170176 @default.
• W1994501315 creator A5029963886 @default.
• W1994501315 creator A5030592365 @default.
• W1994501315 creator A5044524261 @default.
• W1994501315 creator A5062048714 @default.
• W1994501315 creator A5062685867 @default.
• W1994501315 creator A5065656639 @default.
• W1994501315 creator A5068822894 @default.
• W1994501315 creator A5072650079 @default.
• W1994501315 creator A5079152590 @default.
• W1994501315 creator A5082906150 @default.
• W1994501315 creator A5088365145 @default.
• W1994501315 creator A5088591443 @default.
• W1994501315 date "2010-09-01" @default.
• W1994501315 modified "2023-10-14" @default.
• W1994501315 title "ACR Appropriateness Criteria® on Colorectal Cancer Screening" @default.
• W1994501315 cites W1562197307 @default.
• W1994501315 cites W1965618761 @default.
• W1994501315 cites W1969716514 @default.
• W1994501315 cites W1976975876 @default.
• W1994501315 cites W1977155561 @default.
• W1994501315 cites W1978955158 @default.
• W1994501315 cites W1980428297 @default.
• W1994501315 cites W1981011142 @default.
• W1994501315 cites W1982278351 @default.
• W1994501315 cites W1985381776 @default.
• W1994501315 cites W1991397269 @default.
• W1994501315 cites W1991594881 @default.
• W1994501315 cites W1996634835 @default.
• W1994501315 cites W1997125643 @default.
• W1994501315 cites W1997829580 @default.
• W1994501315 cites W2004638113 @default.
• W1994501315 cites W2014495259 @default.
• W1994501315 cites W2015210932 @default.
• W1994501315 cites W2018247165 @default.
• W1994501315 cites W2018735982 @default.
• W1994501315 cites W2020239199 @default.
• W1994501315 cites W2025869695 @default.
• W1994501315 cites W2027751334 @default.
• W1994501315 cites W2030285137 @default.
• W1994501315 cites W2032822958 @default.
• W1994501315 cites W2034220268 @default.
• W1994501315 cites W2039214528 @default.
• W1994501315 cites W2043539979 @default.
• W1994501315 cites W2046686567 @default.
• W1994501315 cites W2048998416 @default.
• W1994501315 cites W2051323874 @default.
• W1994501315 cites W2056919744 @default.
• W1994501315 cites W2059003341 @default.
• W1994501315 cites W2059971518 @default.
• W1994501315 cites W2067940389 @default.
• W1994501315 cites W2068467622 @default.
• W1994501315 cites W2068615388 @default.
• W1994501315 cites W2069430032 @default.
• W1994501315 cites W2072375379 @default.
• W1994501315 cites W2072878220 @default.
• W1994501315 cites W2077390904 @default.
• W1994501315 cites W2095858886 @default.
• W1994501315 cites W2096792435 @default.
• W1994501315 cites W2097786984 @default.
• W1994501315 cites W2100313351 @default.
• W1994501315 cites W2104433373 @default.
• W1994501315 cites W2107348187 @default.
• W1994501315 cites W2107745817 @default.
• W1994501315 cites W2108063121 @default.
• W1994501315 cites W2109608605 @default.
• W1994501315 cites W2113414362 @default.
• W1994501315 cites W2116538834 @default.
• W1994501315 cites W2118772243 @default.
• W1994501315 cites W2118835794 @default.
• W1994501315 cites W2120087420 @default.
• W1994501315 cites W2120507833 @default.
• W1994501315 cites W2123636997 @default.
• W1994501315 cites W2128988020 @default.
• W1994501315 cites W2130474662 @default.
• W1994501315 cites W2136864841 @default.
• W1994501315 cites W2139879861 @default.
• W1994501315 cites W2142860750 @default.
• W1994501315 cites W2144198467 @default.
• W1994501315 cites W2145602937 @default.
• W1994501315 cites W2149270770 @default.
• W1994501315 cites W2154240563 @default.
• W1994501315 cites W2156553666 @default.
• W1994501315 cites W2171248706 @default.
• W1994501315 cites W2316626841 @default.
• W1994501315 cites W2321845872 @default.
• W1994501315 cites W2324989449 @default.
• W1994501315 cites W2333024423 @default.
• W1994501315 cites W2341597406 @default.
• W1994501315 cites W2413620081 @default.
• W1994501315 cites W4235329037 @default.
• W1994501315 doi "https://doi.org/10.1016/j.jacr.2010.05.005" @default.
• W1994501315 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20816627" @default.
• W1994501315 hasPublicationYear "2010" @default.

• next